TABLE 2.

Five-year cancer specific survival stratified by stage for all cases and those with ≥8 LN assessed.

STAGE	LBA	SBA		Duodenal		Jejunal/Ileal
All Patients	CSS	CSS	Difference*	CSS	Difference*	CSS	Difference*
I	93.2%	65.3%	27.9%	59.8%	33.4%	80.4%	12.8%
II	83.8%	55.0%	28.8%	47.6%	36.2%	62.8%	21.0%
III	62.7%	40.0%	22.7%	38.6%	24.1%	42.2%	20.5%
Patients with ≥8 LN
I	93.3%	80.3%	13.0%	79.3%	14.0%	81.6%	11.7%
II	85.8%	69.9%	15.9%	70.9%	14.9%	69.5%	16.3%
III	63.6%	45.1%	18.5%	44.0%	19.6%	47.1%	16.5%

^*In comparison to LBA; Cancer specific survival adjusted by age, sex, race, tumor grade;

Abbreviations: SBA, small bowel adenocarcinoma; LBA, large bowel adenocarcinoma; LN, lymph node.